Pharma & Biotech
BioNTech’s COO Cashes Out $5.5 Million Just as Cancer Pipeline Momentum Builds
The rally in BioNTech shares this month has been one of the sector's standout stories, but a hefty insider sale...
Novo Nordisk’s Teen Pill Win Offers a Rebound, But the Payer Puzzle Remains Unsolved
Novo Nordisk closed the week with a 6.4% bounce to €35.09, its best single-day showing in months, after unveiling positive...
Bayer’s High-Stakes Summer: A $7.25 Billion Settlement and a Pivotal Supreme Court Hearing
Bayer is entering a defining period for its legal and financial future. The German life sciences group has secured preliminary...
Gerresheimer’s Accounting Crisis Deepens as BaFin Widens Probe
The stock has clawed back 46 percent from its February nadir, but the underlying picture at Gerresheimer remains fraught with...
BioNTech’s Cancer Pipeline Steals the Show as COVID Vaccine Woes Mount
The narrative around BioNTech is undergoing a quiet but decisive shift. While the Mainz-based biotech’s legacy COVID-19 vaccine business sputters,...
Bayer’s Cash Flow Squeeze: Legal Bills Weigh Heavily as Supreme Court Date Nears
Bayer shareholders endured a rough session on Friday as the stock shed nearly 3% to close at €38.87, despite management's...
Gerresheimer Draws a Crowd for Centor Sale as New Technology Deal Offers Operational Lift
The Düsseldorf-based packaging specialist is navigating one of the most challenging periods in its history, but two developments this week...
Bayer Faces a Fork in the Road: Supreme Court Showdown Meets Shareholder Austerity
Bayer enters one of its most consequential weeks in years, with a Supreme Court hearing on glyphosate liability looming just...
Novo Nordisk’s Washington Shuffle and Teen Pill Progress Mask a Grim Market Reality
The Danish drugmaker is fighting on multiple fronts — and losing ground on most of them. While Novo Nordisk celebrates...
BioNTech’s ADC Breakthrough Fuels Rally as Oncology Pivot Gathers Pace
The numbers tell a stark story of transition. BioNTech’s Covid vaccine revenue is sliding toward a projected €2.0-2.3 billion for...
Popular News
-
SunHydrogen Set for European Debut with Groundbreaking Technology
-
Walgreens Implements Deep Restructuring Following Private Buyout
-
Exploring the Rise of AI in Empowering Business and Personal Growth: Trends and Innovations
-
Trade Desk Shares Face Mounting Pressure as Tariff Warnings Materialize
-
Kraft Heinz Stock: A Contradiction in Market Sentiment
